Superior efficacy of letrozole versus tamoxifen as first-line therapy

被引:9
作者
Buzdar, AU [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1200/JCO.2002.20.3.876
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:876 / 877
页数:2
相关论文
共 13 条
[1]   Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].
Bonneterre, J ;
Thürlimann, B ;
Robertson, JFR ;
Krzakowski, M ;
Mauriac, L ;
Koralewski, P ;
Vergote, I ;
Webster, A ;
Steinberg, M ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757
[2]  
Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO
[3]  
2-Y
[4]   Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate [J].
Buzdar, A ;
Douma, J ;
Davidson, N ;
Elledge, R ;
Morgan, M ;
Smith, R ;
Porter, L ;
Nabholtz, J ;
Xiang, X ;
Brady, C .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3357-3366
[5]   Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate [J].
Dombernowsky, P ;
Smith, I ;
Falkson, G ;
Leonard, R ;
Panasci, L ;
Bellmunt, J ;
Bezwoda, W ;
Gardin, G ;
Gudgeon, A ;
Morgan, M ;
Fornasiero, A ;
Hoffmann, W ;
Michel, J ;
Hatschek, T ;
Tjabbes, T ;
Chaudri, HA ;
Hornberger, U ;
Trunet, PF .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :453-461
[6]  
GALE KE, 1994, CANCER, V73, P354, DOI 10.1002/1097-0142(19940115)73:2<354::AID-CNCR2820730220>3.0.CO
[7]  
2-J
[8]   RANDOMIZED CLINICAL-TRIAL OF TAMOXIFEN ALONE OR COMBINED WITH FLUOXYMESTERONE IN POSTMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER [J].
INGLE, JN ;
TWITO, DI ;
SCHAID, DJ ;
CULLINAN, SA ;
KROOK, JE ;
MAILLIARD, JA ;
MARSCHKE, RF ;
LONG, HJ ;
GERSTNER, JG ;
WINDSCHITL, HE ;
EVERSON, LK ;
PFEIFLE, DM .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :825-831
[9]   Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:: Results of a phase III study of the international letrozole breast cancer group [J].
Mouridsen, H ;
Gershanovich, M ;
Sun, Y ;
Pérez-Carrión, R ;
Boni, C ;
Monnier, A ;
Apffelstaedt, J ;
Smith, R ;
Sleeboom, HP ;
Jänicke, F ;
Pluzanska, A ;
Dank, M ;
Becquart, D ;
Bapsy, PP ;
Salminen, E ;
Snyder, R ;
Lassus, M ;
Verbeek, JA ;
Staffler, B ;
Chaudri-Ross, HA ;
Dugan, M .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2596-2606
[10]  
Mouridsen H., 2000, European Journal of Cancer, V36, pS88